Press Room

Find news and updates from PhRMA, representing the country’s leading biopharmaceutical research companies. Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as cancer, Alzheimer’s disease, cystic fibrosis and Parkinson’s.

Latest News from PhRMA

PhRMA Recognizes 2016 Research & Hope Award Recipients

September 14, 2016

The Pharmaceutical Research and Manufacturers of America (PhRMA) announced the recipients of the 2016 Research & Hope Awards.

Read More

Scott Olsen to Lead Federal Advocacy at PhRMA

September 13, 2016

PhRMA today announced Scott Olsen will join the association as senior vice president for federal advocacy.

Read More

PhRMA and Lupus Foundation of America Report More Than 300 Medicines in Development for Autoimmune Diseases

September 12, 2016

PhRMA and Lupus Foundation released a report that highlights tremendous progress in the fight against autoimmune diseases.

Read More

PhRMA Statement on Need to Modernize FDA Regulations Governing Information-Sharing about Medicines

August 31, 2016

Patients, payers and providers seek more science-based information about the safety, effectiveness and value of treatments for patients, but FDA’s current federal regulations governing information-sharing about medicines have not kept up with this new reality.

Read More

PhRMA Statement on CMS Part D Data Release

August 18, 2016

The Medicare Part D cost data released today are misleading and do not accurately represent what Medicare pays for prescription drugs. The data exclude the substantial discounts and rebates negotiated directly between manufacturers and Part D plans to deliver value to beneficiaries.

Read More

Statement: Prescription Drug User Fee Act Reauthorization

July 15, 2016

PDUFA is vital to enabling the U.S. Food and Drug Administration to fulfill its mission of protecting public health.

Read More

PhRMA Welcomes Five New Member Companies

July 15, 2016

PhRMA announced today three biopharmaceutical research companies joined the association as members and two transitioned from research associates to full members.

Read More

James C. Stansel is new Executive V.P. & General Counsel

July 12, 2016

PhRMA today announced Stansel will join the organization as executive vice president and general counsel. He will oversee the organization’s legal department.

Read More

Brian Toohey to Lead International Advocacy at PhRMA

June 30, 2016

PhRMA announces that Brian Toohey will join the association as Senior Vice President for International Advocacy.

Read More

Response to Colombia's Declaration of Public Interest

June 10, 2016

PhRMA is very disappointed that Colombia has decided to issue a Declaration of Public Interest as a prelude to imposing additional price cuts on a proven cancer medicine.

Read More